Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project-Reference-Cited by-同舟云学术

Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project

Published:2019-11-05 Issue:9 Volume:38 Page:2215-2220
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Hurle Rodolfo,Casale Paolo,Saita Alberto,Colombo Piergiuseppe,Elefante Grazia Maria,Lughezzani Giovanni,Fasulo Vittorio,Paciotti Marco,Domanico Luigi,Bevilacqua Giulio,Maffei Davide,Diana Pietro,Frego Nicola,Sandri Maria Teresa,Maura Federica,Morenghi Emanuela,Buffi Nicolò M.,Guazzoni Giorgio,Lazzeri Massimo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-03002-3.pdf

Reference25 articles.

1. Rieken M, Xylinas E, Kluth L et al (2014) Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder. Eur Urol 65:201

2. Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466

3. Brausi M, Collette L, Kurth K et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta-T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523

4. Soloway MS, Bruck DS, Kim SS (2003) Expectant management of small, recurrent, noninvasive papillary bladder tumours. J Urol 170:438

5. Martinez Caceres P, Hidalgo Arroyo JG, Chechile Toniolo GE (2005) Is it necessary to always treat the relapses of superficial bladder tumour at the moment of diagnosis? Preliminary communication. Actas Urol Esp 29:567

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of circular RNAs (CircANXA2 and CircFBXW7) in bladder cancer;African Journal of Urology;2024-08-17

2. Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor;BJU International;2024-05-08

3. Biochemical and molecular study of extracellular MiR-21-5p and MiR-99-5p as diagnostic biomarkers of urothelial bladder carcinoma;Gene Reports;2023-09

4. Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?;Cancers;2023-07-19

5. The role of long non-coding RNA UCA1 and MALAT1 in bladder cancer patients;Human Gene;2023-05